Fletcher, Jonathan A.

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine

Gastrointestinal Tumor Research and TreatmentMast cells and histamine

Cited by 4,389

The landscape of somatic copy-number alteration across human cancers

Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature

Cancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalities

Cited by 4,017

Limitations of Chromosome Classification by Multicolor Karyotyping

Lee, C., Gisselsson, D., Jin, C., Nordgren, A., Ferguson, D. O., Blennow, E., Fletcher, J. A., & Morton, C. C. (2001) · The American Journal of Human Genetics

Genomic variations and chromosomal abnormalitiesPrenatal Screening and Diagnostics

Cited by 82

Aberrant AKT activation drives well-differentiated liposarcoma

Gutierrez, A., Snyder, E. L., Marino-Enriquez, A., Zhang, Y.-X., Sioletic, S., Kozakewich, E., Grebliunaite, R., Ou, W.-B., Sicinska, E., Raut, C. P., et al. (2011) · Proceedings of the National Academy of Sciences

Sarcoma Diagnosis and TreatmentPI3K/AKT/mTOR signaling in cancer

Cited by 58

Targeting SALL4 by entinostat in lung cancer

Yong, K. J., Li, A., Ou, W.-B., Hong, C. K. Y., Zhao, W., Wang, F., Tatetsu, H., Yan, B., Qi, L., Fletcher, J. A., et al. (2016) · Oncotarget

Histone Deacetylase Inhibitors ResearchLung Cancer Research Studies

Cited by 41

Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3

Yang, P., Chen, W., Li, X., Eilers, G., He, Q., Liu, L., Wu, Y., Wu, Y., Yu, W., Fletcher, J. A., et al. (2016) · Oncotarget

Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 21